Treatment of CNS Malignancies with a Recombinant Oncolytic Poliovirus

Publisher： Bentham Science Publishers

ISSN： 1567-2697

Source： Drug Design Reviews - Online, Vol.2, Iss.3, 2005-05, pp. : 233-241

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Oncolytic poliovirus against malignant glioma

By Goetz Christian   Dobrikova Elena   Shveygert Mayya   Dobrikov Mikhail   Gromeier Matthias  

Future Virology, Vol. 6, Iss. 9, 2011-09 ,pp. : 1045-1058

Future Medicine

Access to resources Recommend Favorite

Recombinant Immunotoxins for the Treatment of Chemoresistant Hematologic Malignancies

By  

Current Pharmaceutical Design, Vol. 15, Iss. 23, 2009-08 ,pp. : 2652-2664

Bentham Science Publishers

Access to resources Recommend Favorite

Oncolytic viruses for the treatment of malignant glioma

By Merrill Melinda K   Selznick Lee A   Gromeier Matthias  

Expert Opinion on Therapeutic Patents, Vol. 16, Iss. 3, 2006-03 ,pp. : 363-371

Informa Healthcare

Access to resources Recommend Favorite

Oncolytic Virotherapy for Breast Cancer Treatment

By  

Current Gene Therapy, Vol. 18, Iss. 4, 2018-08 ,pp. : 192-205

Bentham Science Publishers

Access to resources Recommend Favorite

Tumour Vaccine Approaches for CNS Malignancies: Progress to Date

By Ebben Johnathan D.   Rocque Brandon G.   Kuo John S.  

Drugs, Vol. 69, Iss. 3, 2009-02 ,pp. : 241-249

Adis International

Access to resources Recommend Favorite